Clinical Laboratories

Grundium: As aging populations bring higher rates of chronic and complex diseases, the volume of patients requiring fast, accurate diagnosis is outpacing the availability of pathologists, cytologists, and other qualified staff, placing...

The Future of Precision Medicine Starts at the Moment of Diagnosis OCTOBER 28, 2025 | 11:30AM ET | VIRTUAL EVENT Join Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision...

VISTA, California, September 30, 2025 – Leica Biosystems is proud to announce the launch of CytoVision DX, a next-generation image capture, analysis, and case management system purpose-built for clinical cytogenetics laboratories. Now CE-IVDR...

Proscia: Delivering a menu of H&E, IHC, and special stains on the Concentriq platform PHILADELPHIA and LOS ANGELES – September 24, 2025 – Proscia®, a pathology AI company, is introducing virtual staining in...

Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI's datasets from 7 million slides, perhaps most of...

The latest from the Proscia blog Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire...